Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased ...

Patients with pulmonary hypertension associated with congenital heart disease make up an increasing proportion of the total pulmonary hypertension population who bring with them added complexity ...

Sitting in his spacious office with a view of the Black Sea, Tayfun Denizer smiles: his rainbow trout, raised in submerged ...

Polyvascular disease, defined as the presence of atherosclerotic disease involving ≥2 vascular beds (coronary, peripheral, or cerebrovascular), is common among patients with PAD and has recently ...

These people had a 20 per cent higher risk of high blood pressure, heart disease and stroke. “No matter how much fibre they ate, their cardiovascular risk did not improve,” Prof Marques said.

His experience highlights how fatty liver disease can suddenly accelerate after years of stability. The progression from manageable condition to advanced cirrhosis demonstrates the unpredictable ...

Los Angeles Times sports columnist and former ESPN "Around the Horn" panelist Bill Plaschke has Parkinson's disease, he revealed in his Sunday column for The Times.

When we think about health red flags, kidney problems don’t always come to mind right away — but maybe they should. Our kidneys work 24/7, filtering waste, balancing fluids, regulating blood ...

As the University of Minnesota's Center for Infectious Disease Research and Policy shared in mid-May, five South American countries confirmed 212 cases of yellow fever and 85 deaths related to the ...

A groundbreaking blood test developed at the Mayo Clinic offers a simpler, more accurate way to detect early signs of Alzheimer's disease. With 95% se ...

In the soft earth beneath the threshold of a Bronze Age home, a disc of bread lay waiting. It had been torn, charred, and buried—sealed into the foundation of a house that once stood in what is now ...

Otsuka's experimental therapy for a potentially life-threatening kidney disease more than halved severe levels of protein in the urine of patients, intensifying the battle for an effective new ...